News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Yale Co-Leads New National Consortium for Rare Skin Disorders
October 12, 2026 - Grantee/Partner News
- Our Impact on Rare Diseases
- Rare Diseases Clinical Research Network (RDCRN)
A Technology Development Center Uses Human-Based Models to Discover Potential Treatments for Fibrotic Diseases
October 9, 2026 - NCATS News
- 3-D Tissue Bioprinting
A multi-institute collaboration, including NCATS, is using human-based 3-D models, drug screening and AI to study fibrotic diseases and accelerate the identification of potential safe and efficacious treatments.
Read ArticleGroundbreaking Ovarian Cancer Research Targets Cells Fueling Tumor Growth
July 23, 2025 - Grantee/Partner News
- Chemistry Technology
AI Serves as ‘Crystal Ball’ for Predicting Outcomes in Hospitalized Cirrhosis Patients
July 23, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
VCU-Led Global Research Team Uses AI to Improve Prediction of Death Risk for Hospitalized Cirrhosis Patients
July 23, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Gene Editing Reverses Symptoms of Rare Brain Disorder in Mice
July 22, 2025 - Grantee/Partner News
- Somatic Cell Genome Editing (SCGE)
New 3D Tissue Model May Speed Better Therapies for Fibrosis
July 22, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
A Decade-Long Program Investigating Understudied Proteins Builds a Foundation for the Future
July 21, 2025 - NCATS News
- Illuminating Druggable Genome (IDG)
- Our Impact on Drug Discovery and Development
Since 2013, the Illuminating the Druggable Genome program has helped researchers learn about understudied protein families to find potential therapeutics.